Entry |
|
Symbol |
ADCY2, AC2, HBAC2
|
Name |
(RefSeq) adenylate cyclase 2
|
KO |
|
Organism |
|
Pathway |
hsa04072 | Phospholipase D signaling pathway |
hsa04213 | Longevity regulating pathway - multiple species |
hsa04261 | Adrenergic signaling in cardiomyocytes |
hsa04270 | Vascular smooth muscle contraction |
hsa04723 | Retrograde endocannabinoid signaling |
hsa04750 | Inflammatory mediator regulation of TRP channels |
hsa04914 | Progesterone-mediated oocyte maturation |
hsa04923 | Regulation of lipolysis in adipocytes |
hsa04925 | Aldosterone synthesis and secretion |
hsa04927 | Cortisol synthesis and secretion |
hsa04928 | Parathyroid hormone synthesis, secretion and action |
hsa04935 | Growth hormone synthesis, secretion and action |
hsa05163 | Human cytomegalovirus infection |
hsa05166 | Human T-cell leukemia virus 1 infection |
hsa05207 | Chemical carcinogenesis - receptor activation |
|
Network |
|
Element |
N00288 | PTH-PTH1R-PKA signaling pathway |
N00297 | ACTH-cortisol signaling pathway |
N00298 | CYP11B1-CYP11B2 fusion to ACTH-cortisol signaling pathway |
N00321 | Mutation-activated GNAS to ACTH-cortisol signaling pathway |
N00324 | CRHR-PKA-ACTH signaling pathway |
N00325 | Mutation-inactivated RASD1 to CRHR-PKA-ACTH signaling pathway |
N00326 | Mutation-activated GNAS to CRHR-PKA-ACTH signaling pathway |
N00327 | Mutation-inactivated PRKAR1A to CRHR-PKA-ACTH signaling pathway |
N00403 | CX3CR1-GNAI-AC-PKA signaling pathway |
N00782 | TSH-TG signaling pathway |
N00885 | LHCGR-GNAS-PKA signaling pathway |
N00910 | GHRHR-PKA-GH signaling pathway |
N00922 | FSHR-GNAS-PKA signaling pathway |
N01345 | EP/NE-ADRB-cAMP signaling pathway |
N01346 | Nicotine/NNK to cAMP signaling pathway |
N01688 | ADRB3-UCP1 signaling pathway |
N01766 | CX3CR1-GNAI-AC signaling pathway |
N01878 | Glutamate-GRM-GNAQ/S signaling pathway |
N01879 | Glutamate-GRM-GNAI/O signaling pathway |
N01888 | GABA-GABBR-GNAI/O signaling pathway |
N01901 | Serotonin-HTR1/5-GNAI/O signaling pathway |
N01903 | Norepinephrine-ADRA2-GNAI/O signaling pathway |
N01904 | Norepinephrine-ADRB-GNAS signaling pathway |
N01908 | ADP/UDP-glucose-P2RY-GNAI/O signaling pathway |
N01913 | Melanocortin receptor signaling, MSH |
N01914 | Melanocortin receptor signaling, AgRP |
|
Drug target |
|
Brite |
KEGG Orthology (KO) [BR:hsa00001]
09100 Metabolism
09104 Nucleotide metabolism
00230 Purine metabolism
108 (ADCY2)
09130 Environmental Information Processing
09132 Signal transduction
04015 Rap1 signaling pathway
108 (ADCY2)
04371 Apelin signaling pathway
108 (ADCY2)
04020 Calcium signaling pathway
108 (ADCY2)
04072 Phospholipase D signaling pathway
108 (ADCY2)
04024 cAMP signaling pathway
108 (ADCY2)
04022 cGMP-PKG signaling pathway
108 (ADCY2)
09133 Signaling molecules and interaction
04082 Neuroactive ligand signaling
108 (ADCY2)
04081 Hormone signaling
108 (ADCY2)
09140 Cellular Processes
09143 Cell growth and death
04114 Oocyte meiosis
108 (ADCY2)
09144 Cellular community - eukaryotes
04540 Gap junction
108 (ADCY2)
09150 Organismal Systems
09151 Immune system
04611 Platelet activation
108 (ADCY2)
04062 Chemokine signaling pathway
108 (ADCY2)
09152 Endocrine system
04911 Insulin secretion
108 (ADCY2)
04922 Glucagon signaling pathway
108 (ADCY2)
04923 Regulation of lipolysis in adipocytes
108 (ADCY2)
04912 GnRH signaling pathway
108 (ADCY2)
04913 Ovarian steroidogenesis
108 (ADCY2)
04915 Estrogen signaling pathway
108 (ADCY2)
04914 Progesterone-mediated oocyte maturation
108 (ADCY2)
04921 Oxytocin signaling pathway
108 (ADCY2)
04926 Relaxin signaling pathway
108 (ADCY2)
04935 Growth hormone synthesis, secretion and action
108 (ADCY2)
04918 Thyroid hormone synthesis
108 (ADCY2)
04928 Parathyroid hormone synthesis, secretion and action
108 (ADCY2)
04916 Melanogenesis
108 (ADCY2)
04925 Aldosterone synthesis and secretion
108 (ADCY2)
04927 Cortisol synthesis and secretion
108 (ADCY2)
09153 Circulatory system
04261 Adrenergic signaling in cardiomyocytes
108 (ADCY2)
04270 Vascular smooth muscle contraction
108 (ADCY2)
09154 Digestive system
04970 Salivary secretion
108 (ADCY2)
04971 Gastric acid secretion
108 (ADCY2)
04972 Pancreatic secretion
108 (ADCY2)
04976 Bile secretion
108 (ADCY2)
09156 Nervous system
04724 Glutamatergic synapse
108 (ADCY2)
04727 GABAergic synapse
108 (ADCY2)
04725 Cholinergic synapse
108 (ADCY2)
04723 Retrograde endocannabinoid signaling
108 (ADCY2)
09157 Sensory system
04750 Inflammatory mediator regulation of TRP channels
108 (ADCY2)
09149 Aging
04211 Longevity regulating pathway
108 (ADCY2)
04213 Longevity regulating pathway - multiple species
108 (ADCY2)
09159 Environmental adaptation
04713 Circadian entrainment
108 (ADCY2)
04714 Thermogenesis
108 (ADCY2)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
108 (ADCY2)
05207 Chemical carcinogenesis - receptor activation
108 (ADCY2)
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
108 (ADCY2)
05163 Human cytomegalovirus infection
108 (ADCY2)
09165 Substance dependence
05032 Morphine addiction
108 (ADCY2)
09166 Cardiovascular disease
05414 Dilated cardiomyopathy
108 (ADCY2)
09167 Endocrine and metabolic disease
04934 Cushing syndrome
108 (ADCY2)
09176 Drug resistance: antineoplastic
01522 Endocrine resistance
108 (ADCY2)
Enzymes [BR:hsa01000]
4. Lyases
4.6 Phosphorus-oxygen lyases
4.6.1 Phosphorus-oxygen lyases (only sub-subclass identified to date)
4.6.1.1 adenylate cyclase
108 (ADCY2)
|
SSDB |
|
Motif |
|
Other DBs |
|
LinkDB |
|
Position |
5:7396138..7830081
|
AA seq |
1091 aa
MWQEAMRRRRYLRDRSEEAAGGGDGLPRSRDWLYESYYCMSQQHPLIVFLLLIVMGSCLA
LLAVFFALGLEVEDHVAFLITVPTALAIFFAIFILVCIESVFKKLLRLFSLVIWICLVAM
GYLFMCFGGTVSPWDQVSFFLFIIFVVYTMLPFNMRDAIIASVLTSSSHTIVLSVCLSAT
PGGKEHLVWQILANVIIFICGNLAGAYHKHLMELALQQTYQDTCNCIKSRIKLEFEKRQQ
ERLLLSLLPAHIAMEMKAEIIQRLQGPKAGQMENTNNFHNLYVKRHTNVSILYADIVGFT
RLASDCSPGELVHMLNELFGKFDQIAKENECMRIKILGDCYYCVSGLPISLPNHAKNCVK
MGLDMCEAIKKVRDATGVDINMRVGVHSGNVLCGVIGLQKWQYDVWSHDVTLANHMEAGG
VPGRVHISSVTLEHLNGAYKVEEGDGDIRDPYLKQHLVKTYFVINPKGERRSPQHLFRPR
HTLDGAKMRASVRMTRYLESWGAAKPFAHLHHRDSMTTENGKISTTDVPMGQHNFQNRTL
RTKSQKKRFEEELNERMIQAIDGINAQKQWLKSEDIQRISLLFYNKVLEKEYRATALPAF
KYYVTCACLIFFCIFIVQILVLPKTSVLGISFGAAFLLLAFILFVCFAGQLLQCSKKASP
LLMWLLKSSGIIANRPWPRISLTIITTAIILMMAVFNMFFLSDSEETIPPTANTTNTSFS
ASNNQVAILRAQNLFFLPYFIYSCILGLISCSVFLRVNYELKMLIMMVALVGYNTILLHT
HAHVLGDYSQVLFERPGIWKDLKTMGSVSLSIFFITLLVLGRQNEYYCRLDFLWKNKFKK
EREEIETMENLNRVLLENVLPAHVAEHFLARSLKNEELYHQSYDCVCVMFASIPDFKEFY
TESDVNKEGLECLRLLNEIIADFDDLLSKPKFSGVEKIKTIGSTYMAATGLSAVPSQEHS
QEPERQYMHIGTMVEFAFALVGKLDAINKHSFNDFKLRVGINHGPVIAGVIGAQKPQYDI
WGNTVNVASRMDSTGVLDKIQVTEETSLVLQTLGYTCTCRGIINVKGKGDLKTYFVNTEM
SRSLSQSNVAS |
NT seq |
3276 nt +upstreamnt +downstreamnt
atgtggcaggaggcgatgcggcgccgccgctacctgcgggaccgctccgaggaggcggcg
ggcggcggagacgggctgccgcggtcccgggactggctctacgagtcctactactgcatg
agccagcagcacccgctcatcgtcttcctgctgctcatcgtcatgggctcctgcctcgcc
ctgctcgccgtcttcttcgcgctcgggctggaagttgaagaccatgtggcgtttctaata
acagttccaactgccctggcgattttctttgcgatatttatcctggtctgcatcgagtct
gtgtttaagaagctgctgcgcctcttctcgttggtgatatggatatgccttgttgccatg
ggatacctgttcatgtgttttggaggcaccgtctctccctgggaccaggtatcgttcttc
ctcttcatcatcttcgtggtgtacaccatgctgcccttcaacatgcgagacgccatcatt
gccagcgtcctcacctcctcctcccacaccatcgtgcttagcgtctgcctgtctgcaaca
ccgggaggcaaggagcacctggtctggcagatcctggccaatgtgatcattttcatctgt
gggaacctggcgggagcctaccataagcacctcatggaactcgctcttcagcaaacatat
caggacacctgtaattgcatcaagtcgcggatcaagttggaatttgaaaaacgtcaacag
gagcggcttctgctctccctgctgccggcccacatcgccatggagatgaaagcggagatc
atccagaggctgcagggccccaaggcgggccagatggagaacacaaataacttccacaac
ctgtatgtgaagcggcatacaaacgtgagcatcttatacgctgacatcgttggctttacc
cggctggcaagtgactgctccccgggagaactagtccacatgctgaatgagctctttgga
aagtttgatcaaattgcaaaggagaatgaatgcatgagaattaaaattttaggagactgc
tactactgtgtatctggactccctatatctctccctaaccatgccaagaactgtgtgaaa
atggggctggacatgtgtgaagccataaagaaagtgagggatgctactggagttgatatc
aacatgcgcgtgggcgtgcattctgggaatgtcctgtgtggcgtgattggtctgcagaag
tggcaatatgatgtgtggtcacatgatgtgaccttggccaaccacatggaagctggaggg
gtccctggacgtgttcacatttcttctgtcaccctggagcacttgaatggcgcttataaa
gtggaggagggagatggtgacattagggacccatatttaaaacagcacctggtgaaaacc
tactttgtgatcaaccccaagggagaacgacggagcccccagcatctcttcagacctcgc
cacacccttgatggagccaaaatgagggcctcggtccgcatgacccggtacttggagtcc
tggggggcagccaagccctttgcacacctacatcacagggacagcatgaccacagagaac
ggcaagatcagcaccacggatgtacccatgggtcagcataattttcaaaatcgcacctta
agaaccaagtcacaaaagaagagatttgaagaagaattgaatgaaaggatgattcaagca
attgatgggattaatgcacagaagcaatggctcaagtctgaagacattcagagaatctca
ctgcttttctataacaaagtactagaaaaagagtaccgggccacggcactgccagcgttc
aagtattatgtgacttgtgcctgtctcatattcttctgcatcttcattgtgcagattctc
gtgctgccaaaaacgtccgtcctgggcatctcctttggggctgcgtttctcttgctggcc
ttcatcctcttcgtctgctttgctggacagcttctgcaatgcagcaaaaaagcctctccc
ctgctcatgtggcttttgaagtcctcgggcatcattgccaaccgcccctggccacggatc
tctctcacgatcatcaccacagccatcatattaatgatggccgtgttcaacatgtttttc
ctgagtgactcagaggaaacaatccctccaactgccaacacaacaaacacaagcttttca
gcctcaaataatcaggtggcgattctgcgtgcgcagaatttatttttcctcccgtacttt
atctacagctgcattctgggactgatatcctgttccgtgttcctgcgggtaaactatgag
ctgaagatgttgatcatgatggtggccttggtgggctacaacaccatcctactccacacc
cacgcccacgtcctgggcgactacagccaggtcttatttgagagaccaggcatttggaaa
gacctgaagaccatgggctctgtgtctctctctatattcttcatcacactgcttgttctg
ggtagacagaatgaatattactgtaggttagacttcttatggaagaacaaattcaaaaaa
gagcgggaggagatagagaccatggagaacctgaaccgcgtgctgctggagaacgtgctt
cccgcgcacgtggctgagcacttcctggccaggagcctgaagaatgaggagctataccac
cagtcctatgactgcgtctgcgtcatgtttgcctccattccggatttcaaagaattttat
acagaatccgacgtgaacaaggagggcttggaatgccttcggctcctgaacgagatcatc
gctgactttgatgatcttctttccaagccaaaattcagtggagttgaaaagattaagacc
attggcagcacatacatggcagcaacaggtctgagcgctgtgcccagccaggagcactcc
caggagcccgagcggcagtacatgcacattggcaccatggtggagtttgcttttgccctg
gtagggaagctggatgccatcaacaagcactccttcaacgacttcaaattgcgagtgggt
attaaccatggacctgtgatagctggtgtgattggagctcagaagccacaatatgatatc
tggggcaacactgtcaatgtggccagtaggatggacagcaccggagtcctggacaaaata
caggttaccgaggagacgagcctcgtcctgcagaccctcggatacacgtgcacctgtcga
ggaataatcaacgtgaaaggaaagggggacctgaagacgtactttgtaaacacagaaatg
tcaaggtccctttcccagagcaacgtggcatcctga |